[{"_id":"551f89b631cae9239deb1ed7","会社名":"あすか製薬(株)【4514】","証券コード":"4514","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月13日","決算月数":"12か月","売上高":"39,501百万円","営業利益":"716百万円","経常利益":"1,031百万円","当期利益":"495百万円","EPS（一株当たり利益）":"17.85円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,219.32円","総資産":"51,269百万円","自己資本":"33,906百万円","資本金":"1,197百万円","有利子負債":"1,557百万円","自己資本比率":"66.1%","ROA（総資産利益率）":"0.96%","ROE（自己資本利益率）":"1.47%","総資産経常利益率":"2.00%","__v":0,"日付":"2015-04-04T06:50:30.371Z"},{"_id":"551f89b631cae9239deb1ed8","会社名":"あすか製薬(株)【4514】","証券コード":"4514","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月14日","決算月数":"12か月","売上高":"40,963百万円","営業利益":"1,061百万円","経常利益":"1,336百万円","当期利益":"1,114百万円","EPS（一株当たり利益）":"40.27円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,202.59円","総資産":"51,770百万円","自己資本":"33,345百万円","資本金":"1,197百万円","有利子負債":"1,782百万円","自己資本比率":"64.4%","ROA（総資産利益率）":"2.20%","ROE（自己資本利益率）":"3.42%","総資産経常利益率":"2.64%","__v":0,"日付":"2015-04-04T06:50:30.371Z"},{"_id":"551f89b631cae9239deb1ed9","会社名":"あすか製薬(株)【4514】","証券コード":"4514","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月14日","決算月数":"12か月","売上高":"40,637百万円","営業利益":"935百万円","経常利益":"1,224百万円","当期利益":"7百万円","EPS（一株当たり利益）":"0.28円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,152.99円","総資産":"49,326百万円","自己資本":"31,809百万円","資本金":"1,197百万円","有利子負債":"1,340百万円","自己資本比率":"64.5%","ROA（総資産利益率）":"0.01%","ROE（自己資本利益率）":"0.02%","総資産経常利益率":"2.29%","__v":0,"日付":"2015-04-04T06:50:30.372Z"},{"_id":"551f89b631cae9239deb1eda","会社名":"あすか製薬(株)【4514】","証券コード":"4514","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月13日","決算月数":"12か月","売上高":"39,501百万円","営業利益":"716百万円","経常利益":"1,031百万円","当期利益":"495百万円","EPS（一株当たり利益）":"17.85円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,219.32円","総資産":"51,269百万円","自己資本":"33,906百万円","資本金":"1,197百万円","有利子負債":"1,557百万円","自己資本比率":"66.1%","ROA（総資産利益率）":"0.96%","ROE（自己資本利益率）":"1.47%","総資産経常利益率":"2.00%","__v":0,"日付":"2015-04-04T06:50:30.375Z"},{"_id":"551f89b631cae9239deb1edb","会社名":"あすか製薬(株)【4514】","証券コード":"4514","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月14日","決算月数":"12か月","売上高":"40,963百万円","営業利益":"1,061百万円","経常利益":"1,336百万円","当期利益":"1,114百万円","EPS（一株当たり利益）":"40.27円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,202.59円","総資産":"51,770百万円","自己資本":"33,345百万円","資本金":"1,197百万円","有利子負債":"1,782百万円","自己資本比率":"64.4%","ROA（総資産利益率）":"2.20%","ROE（自己資本利益率）":"3.42%","総資産経常利益率":"2.64%","__v":0,"日付":"2015-04-04T06:50:30.375Z"},{"_id":"551f89b631cae9239deb1edc","会社名":"あすか製薬(株)【4514】","証券コード":"4514","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月14日","決算月数":"12か月","売上高":"40,637百万円","営業利益":"935百万円","経常利益":"1,224百万円","当期利益":"7百万円","EPS（一株当たり利益）":"0.28円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,152.99円","総資産":"49,326百万円","自己資本":"31,809百万円","資本金":"1,197百万円","有利子負債":"1,340百万円","自己資本比率":"64.5%","ROA（総資産利益率）":"0.01%","ROE（自己資本利益率）":"0.02%","総資産経常利益率":"2.29%","__v":0,"日付":"2015-04-04T06:50:30.375Z"}]